×
S&P 500   4,144.86 (+2.14%)
DOW   33,097.88 (+1.41%)
QQQ   307.81 (+2.83%)
AAPL   148.78 (+3.48%)
MSFT   271.30 (+2.03%)
FB   194.58 (+1.54%)
GOOGL   2,239.84 (+3.90%)
AMZN   2,279.79 (+2.62%)
TSLA   755.82 (+6.79%)
NVDA   187.75 (+5.18%)
BABA   93.24 (-1.31%)
NIO   16.50 (+2.93%)
AMD   102.00 (+3.29%)
CGC   4.88 (-12.07%)
MU   73.10 (+3.54%)
T   21.24 (-0.38%)
GE   78.29 (+1.66%)
F   13.58 (+3.51%)
DIS   109.24 (+3.44%)
AMC   14.39 (+17.66%)
PFE   53.63 (-0.67%)
PYPL   84.94 (+5.62%)
NFLX   194.16 (+1.44%)
S&P 500   4,144.86 (+2.14%)
DOW   33,097.88 (+1.41%)
QQQ   307.81 (+2.83%)
AAPL   148.78 (+3.48%)
MSFT   271.30 (+2.03%)
FB   194.58 (+1.54%)
GOOGL   2,239.84 (+3.90%)
AMZN   2,279.79 (+2.62%)
TSLA   755.82 (+6.79%)
NVDA   187.75 (+5.18%)
BABA   93.24 (-1.31%)
NIO   16.50 (+2.93%)
AMD   102.00 (+3.29%)
CGC   4.88 (-12.07%)
MU   73.10 (+3.54%)
T   21.24 (-0.38%)
GE   78.29 (+1.66%)
F   13.58 (+3.51%)
DIS   109.24 (+3.44%)
AMC   14.39 (+17.66%)
PFE   53.63 (-0.67%)
PYPL   84.94 (+5.62%)
NFLX   194.16 (+1.44%)
S&P 500   4,144.86 (+2.14%)
DOW   33,097.88 (+1.41%)
QQQ   307.81 (+2.83%)
AAPL   148.78 (+3.48%)
MSFT   271.30 (+2.03%)
FB   194.58 (+1.54%)
GOOGL   2,239.84 (+3.90%)
AMZN   2,279.79 (+2.62%)
TSLA   755.82 (+6.79%)
NVDA   187.75 (+5.18%)
BABA   93.24 (-1.31%)
NIO   16.50 (+2.93%)
AMD   102.00 (+3.29%)
CGC   4.88 (-12.07%)
MU   73.10 (+3.54%)
T   21.24 (-0.38%)
GE   78.29 (+1.66%)
F   13.58 (+3.51%)
DIS   109.24 (+3.44%)
AMC   14.39 (+17.66%)
PFE   53.63 (-0.67%)
PYPL   84.94 (+5.62%)
NFLX   194.16 (+1.44%)
S&P 500   4,144.86 (+2.14%)
DOW   33,097.88 (+1.41%)
QQQ   307.81 (+2.83%)
AAPL   148.78 (+3.48%)
MSFT   271.30 (+2.03%)
FB   194.58 (+1.54%)
GOOGL   2,239.84 (+3.90%)
AMZN   2,279.79 (+2.62%)
TSLA   755.82 (+6.79%)
NVDA   187.75 (+5.18%)
BABA   93.24 (-1.31%)
NIO   16.50 (+2.93%)
AMD   102.00 (+3.29%)
CGC   4.88 (-12.07%)
MU   73.10 (+3.54%)
T   21.24 (-0.38%)
GE   78.29 (+1.66%)
F   13.58 (+3.51%)
DIS   109.24 (+3.44%)
AMC   14.39 (+17.66%)
PFE   53.63 (-0.67%)
PYPL   84.94 (+5.62%)
NFLX   194.16 (+1.44%)
FRA:SY1

Symrise (SY1) Stock Forecast, Price & News

€101.70
-0.05 (-0.05%)
(As of 05/26/2022 12:00 AM ET)
Add
Compare
Today's Range
€100.55
€101.75
50-Day Range
€98.40
€114.50
52-Week Range
€56.96
€73.48
Volume
174,686 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
30 days | 90 days | 365 days | Advanced Chart
Receive SY1 News and Ratings via Email

Sign-up to receive the latest news and ratings for Symrise and its competitors with MarketBeat's FREE daily newsletter.

Symrise logo

About Symrise

Symrise AG supplies fragrances, flavorings, cosmetic active ingredients and raw materials, and functional ingredients. It operates through two segments, Taste, Nutrition & Health, and Scent & Care. The Taste, Nutrition & Health segment provides functional ingredients and flavor solutions used in the production of food and beverages; savory flavors; natural and sustainable ingredients for food and beverage manufacturers, baby food, and dietary supplements; product solutions and services for pet food manufacturers; sustainable ingredients and services for aqua feed manufacturers to develop solutions for fish and shrimp farms; and probiotics for food supplements and functional foods. The Scent & Care segment develops, produces, and sells fragrance ingredients and compositions, aroma molecules, cosmetic ingredients, and mint flavors, as well as specific application processes for such substances. This segment's products are used by manufacturers of perfumes, personal care and cosmetic products, cleaning products, detergents, air fresheners, and oral care products. It operates in Europe, Africa, the Middle East, North America, the Asia Pacific, and Latin America. Symrise AG was founded in 1874 and is headquartered in Holzminden, Germany.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Specialty Chemicals
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
11,276
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Optionable
Not Optionable

MarketRank

Overall MarketRank

1.04 out of 5 stars

Analyst Opinion: 2.1Community Rank: 3.1Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -













Symrise (FRA:SY1) Frequently Asked Questions

Is Symrise a buy right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Symrise in the last twelve months. There are currently 3 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" Symrise stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SY1, but not buy additional shares or sell existing shares.
View analyst ratings for Symrise
or view top-rated stocks.

What price target have analysts set for SY1?

4 brokerages have issued 12-month target prices for Symrise's shares. Their forecasts range from €100.00 to €138.00. On average, they anticipate Symrise's share price to reach €120.03 in the next twelve months. This suggests a possible upside of 18.0% from the stock's current price.
View analysts' price targets for Symrise
or view top-rated stocks among Wall Street analysts.

Who are Symrise's key executives?
Symrise's management team includes the following people:
  • Dr. Heinz-Jurgen Bertram, CEO, Pres of Scent and Care, Chairman of Exec. Board & Labour Director (Age 64, Pay $1.66M)
  • Mr. Olaf Klinger, CFO, Head of Fin., Legal & IT Department and Member of Exec. Board (Age 57, Pay $1.02M)
  • Dr. Jean-Yves Parisot, Pres of Taste, Nutrition & Health & Member of Exec. Board (Age 58, Pay $1.33M)
  • Dr. Jürgen Nienhaus, Corp. VP of Operations
  • Mr. Tobias Erfurth, Head of Investor Relation
  • Mr. Roberto Ascoli, Sr. VP of New Bus. Devel. - Scent & Care Division
  • Ms. Béatrice Favre-Bulle, Sr. VP of Scent & Care
  • Mr. Alain Bourdon, Managing Director of Madagascar
  • Mr. Arnaud Bellon, Sr. VP and Global Head of Botanicals & Colors - The Cosmetic Ingredients Division
  • Ms. Marie-Laure Roumiguiere, Head of Global Account Management of EAME - Cosmetic Ingredients Division
What other stocks do shareholders of Symrise own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Symrise investors own include Abbott Laboratories (ABT), Everest Re Group (RE), Ambev (ABEV), Allianz (ALV), Applied Materials (AMAT), Basf (BAS), BRF (BRFS), Daimler (DAI), Givaudan (GVDNY) and iShares Biotechnology ETF (IBB).

What is Symrise's stock symbol?

Symrise trades on the FRA under the ticker symbol "SY1."

What is Symrise's stock price today?

One share of SY1 stock can currently be purchased for approximately €101.70.

How many employees does Symrise have?

Symrise employs 11,276 workers across the globe.

What is Symrise's official website?

The official website for Symrise is www.symrise.com.

How can I contact Symrise?

Symrise's mailing address is Muehlenfeldstrasse 1, HOLZMINDEN, 37603, Germany. The company can be reached via phone at +49-5531-900.

This page was last updated on 5/27/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.